Codes / ICD10CM / D33.7

D33.7 Benign neoplasm of other specified parts of central nervous system

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Benign neoplasm of other specified parts of central nervous system
  • Also known as a non-cancerous growth in other parts of the brain or spinal cord.

Summary

Benign neoplasm of other specified parts of the central nervous system refers to a non-cancerous growth originating in areas of the brain or spinal cord not classified under more specific subcategories. These tumors do not invade surrounding tissues or spread to other parts of the body but can cause symptoms by pressing on nearby structures.

Causes

The exact cause of benign central nervous system neoplasms is not well understood. They may develop due to genetic mutations or arise sporadically without a clear underlying cause.

Risk Factors

  • Family history of brain tumors
  • Genetic syndromes, such as neurofibromatosis or tuberous sclerosis
  • Previous radiation exposure to the head or spine

Symptoms

  • Headaches, often persistent or worsening
  • Nausea or vomiting
  • Changes in vision, balance, or coordination
  • Seizures
  • Cognitive or personality changes
  • Weakness or numbness in limbs

Diagnosis

Diagnosis typically involves a neurological examination, followed by imaging tests such as MRI or CT scans to visualize the tumor. A biopsy may be performed to confirm the diagnosis and rule out malignancy.

Treatment Options

  • Surgical Removal: The primary treatment is surgical resection to alleviate symptoms and remove the tumor when feasible.
  • Observation: Small, asymptomatic tumors may be monitored with regular imaging if surgery is not immediately necessary.
  • Radiation Therapy: Used in cases where surgery is not possible or to treat residual tumor tissue.
  • Medications: Steroids may be prescribed to reduce swelling, and anticonvulsants for seizure control.

Prognosis and Follow-Up

Prognosis is generally favorable for benign neoplasms, as they do not spread. However, outcomes depend on the tumor's location, size, and impact on surrounding structures. Regular follow-up with imaging and neurological evaluations is recommended to monitor for recurrence or growth.

Complications

  • Increased intracranial pressure
  • Neurological deficits (e.g., vision loss, motor weakness)
  • Seizures
  • Hydrocephalus (fluid buildup in the brain)

Lifestyle & Prevention

  • Maintain a healthy lifestyle to support overall brain health.
  • Avoid unnecessary radiation exposure to the head or spine.
  • Follow up with healthcare providers for regular check-ups if risk factors are present.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headaches, sudden neurological changes (e.g., weakness, confusion), seizures, or vision problems.

Tips for Medical Coders

When coding D33.7, ensure documentation specifies the exact location of the benign neoplasm within the central nervous system. Verify that the diagnosis aligns with the "other specified parts" designation and that malignancy has been ruled out. Include details such as imaging findings, biopsy results, and clinical symptoms to support accurate coding.

Book a walkthrough

D33.7 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.